May 9, 2022
EPS Corporation
News Release

Launch of a Consolidated Call Center Service Promoting DCT*1
The EPS Corporation (Head Office: Shinjuku-ku, Tokyo; President and Representative Director:Akira SASA; hereinafter “EPS”) will launch a Consolidated Call Center service promoting DCT toconsolidate support for EP-PharmaLine Co., Ltd. (Head Office: Toshima-ku, Tokyo; President andRepresentative Director: Kanami IKEDA; hereinafter “EP-PharmaLine”) and Group companies.
DCT uses a variety of systems and tools to run clinical trials, but each of these systems and tools isprovided by a different company. This forces subjects participating in clinical trials to contact each
respective company when unsure how to use a particular system or tool.
EPS is launching the Consolidated Call Center service to provide clinical trial subjects with a single
contact point. This will achieve more patient-centric clinical trials by easing the difficulties felt byclinical subjects.

Ahead of the launch of the Consolidated Call Center service, EPS held a web seminar entitled“Revolutionary Consolidated Call Center Service: The Realization of Truly Patient-Centric DCT,”
together with EP-PharmaLine on April 13, 2022. This web seminar introduced the unique features of
the Consolidated Call Center service, the benefits when used in clinical trials, and the EPS support
system provided by the Consolidated Call Center.
The web seminar generated a large amount of interest in the Consolidated Call Center with a post-seminar survey showing that a total of 84.2% participants would like to use the service.
Which kind of call center would you like to utilize? (n=38)

For medical
institutions, 5.3%

No plan toutilize,
15.8%

For clinical
trialsubjects,
21.0%

Both for clinicaltrial subjects
and for medical
institutions,57.9%

Consolidated Call Center
EPS and EP-PharmaLine provide the Consolidated Call Center as a service. EP-PharmaLine contracts
and consolidates the call center services of the companies providing the systems and tools for clinical
trials. EP-PharmaLine call service representatives with medical qualifications then handle any
questions from clinical subjects 24 hours a day, 365 days a year on behalf of the companies providing
the systems and tools.
The Consolidated Call Center service offers a single contact point to more easily tackle issues felt byclinical subjects through professional call center representatives, which should improve the retention
rate in clinical trials. Moreover, this service is not only for clinical subjects but also for clinical staffof the medical institutions running the clinical trials. The Consolidated Call Center handles all
inquiries related to clinical trials, except details of the protocols.
EPS Virtual Go Framework
As a leading company supporting clinical study work, EPS is advancing the Virtual Go framework topromote DCT using its wealth of expertise and experience in data science, which is backed by anextensive track record.

Virtual Go is a generic name for all EPS services used to promote DCT.
Virtual Go always strives to satisfy two core ideas: “virtual/online clinical trials in which patients do
not have to visit medical institutions” and “virtual/online clinical trials in which CRAs*2 do not haveto visit medical institutions.” To do this, EPS handles everything from the proposal to operation andmanagement of various schemes for the trial design and type of disease to promote DCT. This includes
eConsent*3, online medical examinations, DDC*4, eCOA*5, the use of wearable devices, shipment ofdrugs for clinical trials, home-visit nursing, and specimen collection.
About EPS Corporation
EPS launched its business in 1991 as a CRO*6 to comprehensively support clinical studies with thefocus on clinical trials and PMS*7. The company proposes new models to satisfy customers’ needs byleveraging its data science expertise and digital technology cultivated through its extensive trackrecord. These proposals are founded in its Trial GATE concept, which acts as the gateway for all
promotion functions of clinical trials.
About EP-PharmaLine
As a member of the EPS Group, EP-PharmaLine specializes in the pharmaceutical, medical, medical
equipment/device and healthcare industries, and develops and provides solutions that constantly meetcustomer needs in four core services: DI*8 Service - Contact Center Service, BPO*9 Service, MultiChannel Promotion Service, and Healthcare Service. In its call center services, EP-PharmaLine isalso proud to have highest number of certified professionals in Japan (930 persons of pharmacists,nurses, MRs, registered dietitians, nutritionists, veterinarians, registered sales professionals, etc.; asof September 2021).
*1: DCT (Decentralized Clinical Trials)*6: CRO (Contract Research Organization)*2: CRA (Clinical Research Associate)*7: PMS (Post Marketing Surveillance)*3: eConsent (Electronic Consent)*8: DI (Drug Information)*4: DDC (Direct Data Capture)*9: BPO (Business Process Outsourcing)*5: eCOA (Electronic Clinical Outcome Assessment)

Contact:
EPS Corporation
Administration Headquarters
General Affairs Office, Public Relations
E-mail: koho@eps.co.jp